Cytonus Therapeutics

    OverviewSuggest Edit

    Cytonus Therapeutics is a company specializing in immune-oncology and gene therapies. It develops CARGOCYTE cell platform technology to create controllable cell-based immunotherapies to solid and hematologic tumors.
    TypePrivate
    Founded2018
    Websitecytonus.com

    Latest Updates

    Employees (est.) (Jul 2021)3
    Cybersecurity ratingAMore

    Key People/Management at Cytonus Therapeutics

    Remo Moomiaie-Qajar

    Remo Moomiaie-Qajar

    Founder and CEO
    Richard Klemke

    Richard Klemke

    Founder and CSO
    Chris Thorne

    Chris Thorne

    Chairman
    Manisha Narasimhan

    Manisha Narasimhan

    Director
    Show more

    Cytonus Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2018

    Cytonus Therapeutics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    90/100

    SecurityScorecard logo

    Cytonus Therapeutics Online and Social Media Presence

    Embed Graph

    Cytonus Therapeutics Frequently Asked Questions

    • When was Cytonus Therapeutics founded?

      Cytonus Therapeutics was founded in 2018.

    • Who are Cytonus Therapeutics key executives?

      Cytonus Therapeutics's key executives are Remo Moomiaie-Qajar, Richard Klemke and Chris Thorne.

    • How many employees does Cytonus Therapeutics have?

      Cytonus Therapeutics has 3 employees.

    • Who are Cytonus Therapeutics competitors?

      Competitors of Cytonus Therapeutics include Neogene Therapeutics, LXRepair and Strata Oncology.